Multiple Myeloma Clinical Trials in Pembroke Pines, Florida

4 studies are recruiting for multiple myeloma in Pembroke Pines, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

    The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Memorial Cancer Institute, Pembroke Pines, Florida
    Locations
    151 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07518186 on ClinicalTrials.gov

  2. A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

    The study consists of three parts: * Part 1: The primary purpose of this part aims to evaluate the safety, tolerability, and clinical activity of escalating doses of single agent belantamab in participants with refractory multiple myeloma (RRMM) who have received at least 3 prior therapies (4L+). *…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    GSK Investigational Site, Pembroke Pines, Florida
    Locations
    44 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT05714839 on ClinicalTrials.gov

  3. A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

    The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    GSK Investigational Site, Pembroke Pines, Florida
    Locations
    181 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06679101 on ClinicalTrials.gov

  4. A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

    This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who currently show progressive disease.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Millennium Oncology Research Clinic, Pembroke Pines, Florida
    Locations
    13 in total
    Run by
    Oncotherapeutics

    See if you can join NCT03110822 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.